user

Concurrent chemoradiotherapy with weekly docetaxel and cisplatin for locally advanced head and neck cancer: Phase I study

被引：0
|
作者：
Kim, H. S.
Park, K.
Ahn, M. J.
Park, Y.
Lee, S.
Baek, C.
Son, Y.
Jeong, H.
Ahn, Y.
Park, B.
机构：
[1] Samsung Med Ctr, Seoul, South Korea
[2] Hanyang Univ, Coll Med, Seoul 133791, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17026
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Predicitve factors of cisplatin completion/discontinuation in concurrent chemoradiotherapy to locally advanced head and neck cancer patients
    Nakano, K.
    Sato, Y.
    Toshiyasu, T.
    Sato, Y.
    Kawabata, K.
    Takahashi, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S751 - S752
  • [42] Docetaxel, cisplatin, fluorouracil, and leucovorin in locally advanced head and neck cancer
    Janinis, J
    Panagos, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1393 - 1394
  • [43] Capecitabine chemoradiotherapy in locally advanced head and neck cancer - An alternative to cisplatin?
    Mais, L.
    Slevin, N. J.
    Sykes, A. J.
    Yap, B. K.
    Swindell, R.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S50 - S50
  • [44] Postoperative radiotherapy with weekly cisplatin in locally advanced head and neck cancer
    Hervas, A.
    Dominguez, J.
    Candini, D.
    Martin, M.
    Vallejo, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Goshi Nishimura
    Takahide Taguchi
    Masahiro Takahashi
    Osamu Shiono
    Masanori Komatsu
    Daisuke Sano
    Kenichiro Yabuki
    Yasuhiro Arai
    Hideaki Takahashi
    Masaharu Hata
    Nobuhiko Oridate
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 1315 - 1319
  • [46] Phase II trial of concurrent bio-chemoradiotherapy using docetaxel, cisplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Nishimura, Goshi
    Taguchi, Takahide
    Takahashi, Masahiro
    Shiono, Osamu
    Komatsu, Masanori
    Sano, Daisuke
    Yabuki, Kenichiro
    Arai, Yasuhiro
    Takahashi, Hideaki
    Hata, Masaharu
    Oridate, Nobuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1315 - 1319
  • [47] Phase I study of docetaxel, cisplatin and concurrent radiotherapy for locally advanced gastric adenocarcinoma
    Xing, L.
    Lu, H.
    Zhang, J.
    Yu, J.
    Wang, F.
    Yu, X.
    Yu, H.
    Xia, L.
    NEOPLASMA, 2012, 59 (04) : 370 - 375
  • [48] Phase I study of concurrent capecitabine and paclitaxel with radiotherapy in locally advanced head and neck cancer
    Kanani, S
    Suntharalingam, M
    Wolf, J
    Duckham, E
    Gray, WC
    Ord, RA
    RADIOLOGY, 2002, 225 : 506 - 507
  • [49] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
    Komatsu, Masanori
    Shiono, Osamu
    Taguchi, Takahide
    Sakuma, Yasunori
    Nishimura, Goushi
    Sano, Daisuku
    Sakuma, Naoko
    Yabuki, Kenichiro
    Arai, Yasuhiro
    Takahashi, Masahiro
    Isitoya, Junichi
    Oridate, Nobuhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 416 - 421
  • [50] Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: a phase II randomized study
    Paccagnella, A.
    Ghi, M. G.
    Loreggian, L.
    Buffoli, A.
    Koussis, H.
    Mione, C. A.
    Bonetti, A.
    Campostrini, F.
    Gardani, G.
    Ardizzoia, A.
    Dondi, D.
    Guaraldi, M.
    Cavallo, R.
    Tomio, L.
    Gava, A.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1515 - 1522
12345